KT182

Catalog No. :
ACCANT681
CAS No. :
1402612-62-7
Molecular Formula :
C27H26N4O2
Molecular Weight :
438.53

IUPAC Name:(4-(3'-(hydroxymethyl)-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)(2-phenylpiperidin-1-yl)methanone

KT182 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg99%$61.00Login to see priceInquiryInquiry
5mg99%$142.00Login to see priceInquiryInquiry
10mg99%$238.00Login to see priceInquiryInquiry
25mg99%$428.00Login to see priceInquiryInquiry
50mg99%$615.00Login to see priceInquiryInquiry
100mg99%$830.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameKT182
IUPAC Name(4-(3'-(hydroxymethyl)-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)(2-phenylpiperidin-1-yl)methanone
MDL No.MFCD28118914
Molecular FormulaC27H26N4O2
Molecular Weight438.53
SMILESO=C(N1N=NC(C2=CC=C(C3=CC=CC(CO)=C3)C=C2)=C1)N4C(C5=CC=CC=C5)CCCC4
InChI KeyGICNKPZHUCVFNM-UHFFFAOYSA-N
SynonymHY-120177 | KT182, >=98% (HPLC) | SCHEMBL13192356 | BDBM50010335 | (4-(3'-(hydroxymethyl)-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)(2-phenylpiperidin-1-yl)methanone | MLS004256823 | CGC61262 | CS-0077095 | AKOS027263749 | SMR003081898 | [4-[4-[3-(hydro
CAS No.1402612-62-7
PubChem CID53364491

Synthetic Route by SureRoute

1. ACCANT681 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEQGP632 route compound structure diagram
    ACEQGP63287199-15-3 In Stock
  4. Then
  5. ACCANT681 route product structure diagram
    ACCANT6811402612-62-7
Inquiry

2. ACCANT681 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCANT681 route product structure diagram
    ACCANT6811402612-62-7
Inquiry

Comments (0)